Research Report for CoreLogic, Inc.(NYSE:CLGX): Navidea Biopharmaceuticals, Inc.(NYSE:NAVB)

0
1

CoreLogic, Inc. (CLGX) will report its next earnings on Apr 30 AMC. The company reported the earnings of $0.76/Share in the last quarter where the estimated EPS by analysts was $0.71/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 7%.

Many analysts are providing their Estimated Earnings analysis for CoreLogic, Inc. and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $0.78/share. These analysts have also projected a Low Estimate of $0.7/share and a High Estimate of $0.83/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for CoreLogic, Inc. as 441.95 Million. According to these analysts, the Low Revenue Estimate for CoreLogic, Inc. is 432.6 Million and the High Revenue Estimate is 456.2 Million. The company had Year Ago Sales of 459.54 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CLGX to be -8.5%. They are projecting Next Quarter growth of -12.2%. For the next 5 years, CoreLogic, Inc. is expecting Growth of -1.5% per annum, whereas in the past 5 years the growth was 2.12% per annum.

Some buy side analysts are also providing their Analysis on CoreLogic, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.99 and Average Volume (3 months) is 977.12 million. The company’s P/E (price to earnings) ratio is 40.07 and Forward P/E ratio of 16.98.

The company shows its Return on Assets (ROA) value of 2%. The Return on Equity (ROE) value stands at 8.7%. While it’s Return on Investment (ROI) value is 6%.

While looking at the Stock’s Performance, CoreLogic, Inc. currently shows a Weekly Performance of 8.72%, where Monthly Performance is 35.21%, Quarterly performance is 1.55%, 6 Months performance is 22.22% and yearly performance percentage is 20.04%. Year to Date performance value (YTD perf) value is 12.38%. The Stock currently has a Weekly Volatility of 2.58% and Monthly Volatility of 3.65%.

Navidea Biopharmaceuticals, Inc. (NAVB) will report its next earnings on May 14 AMC. The company reported the earnings of $-0.15/Share in the last quarter where the estimated EPS by analysts was $-0.12/share. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -25%.

Many analysts are providing their Estimated Earnings analysis for Navidea Biopharmaceuticals, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

These analysts also forecasted Growth Estimates for the Current Quarter for NAVB to be 70.8%. They are projecting Next Quarter growth of 58.82%. For the next 5 years, Navidea Biopharmaceuticals, Inc. is expecting Growth of 24.24% per annum, whereas in the past 5 years the growth was 56.58% per annum.

Some buy side analysts are also providing their Analysis on Navidea Biopharmaceuticals, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 3.8 and Average Volume (3 months) is 1.45 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -207.5%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 843.3%.

While looking at the Stock’s Performance, Navidea Biopharmaceuticals, Inc. currently shows a Weekly Performance of 104.92%, where Monthly Performance is 257.14%, Quarterly performance is 159.07%, 6 Months performance is 267.65% and yearly performance percentage is 79.86%. Year to Date performance value (YTD perf) value is 98.41%. The Stock currently has a Weekly Volatility of 28.81% and Monthly Volatility of 15.41%.

SHARE